Research & Development
Mylan and Pfizer receive European Commission final approval to combine Upjohn business
16 September 2020 -

It was reported on Tuesday that the European Commission has granted final approval to US-based companies Mylan (NASDAQ: MYL) and Pfizer Inc (NYSE: PFE) for the proposed combination of their Upjohn business.

The European Commission offered conditional approval in April 2020 that was subject to the divestiture of certain of Mylan's products in Europe.

The European Commission approved the proposed divestiture buyers and Mylan signed the contract with those customers on terms that the European Commission has accepted. Both firms have already received approval from the Australian Competition and Consumer Commission and the New Zealand Commerce Commission related to combining this business.



Related Headlines